Norvir and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Norvir (ritonavir) and Ifosfamide (ifosfamide). Common drug interactions include bone density decreased among females and somnolence among males.

The phase IV clinical study analyzes what interactions people have when they take Norvir and Ifosfamide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Norvir?

Norvir has active ingredients of ritonavir. It is often used in hiv infection. eHealthMe is studying from 24,973 Norvir users. Check the latest studies of Norvir.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

On Jul, 09, 2026

11 people who take Norvir and Ifosfamide together, and have interactions are studied.

Norvir and Ifosfamide drug interactions.

What are the common drug interactions of Norvir and Ifosfamide, by gender? *:

female:

Bone density decreased
Depression
Emotional distress
Multiple fractures
Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Upper limb fracture

male:

Somnolence (a state of near-sleep, a strong desire for sleep)
Thrombocytopenia (decrease of platelets in blood)
Neutropenia (an abnormally low number of neutrophils)
Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Encephalopathy (functioning of the brain is affected by some agent or condition)
General physical health deterioration (weak health status)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Mucosal inflammation (infection of mucous membrane)
Visual acuity reduced (reduced clearness of vision)

What are the common drug interactions of Norvir and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Somnolence (a state of near-sleep, a strong desire for sleep)
Neutropenia (an abnormally low number of neutrophils)
Thrombocytopenia (decrease of platelets in blood)

30-39:

Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Visual acuity reduced (reduced clearness of vision)

40-49:

Osteopenia (a condition where bone mineral density is lower than normal)
Osteoporosis (bones weak and more likely to break)
Pain
Upper limb fracture
Bone density decreased
Depression
Emotional distress
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Multiple fractures

50-59:

Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
Encephalopathy (functioning of the brain is affected by some agent or condition)
General physical health deterioration (weak health status)
Mucosal inflammation (infection of mucous membrane)
Thrombocytopenia (decrease of platelets in blood)

60+:

n/a

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 36.36%
Sarcoma (rare cancers that develop in the muscle, bone, nerves, cartilage, tendons, blood vessels and the fatty and fibrous tissues): 2 people, 18.18%
Pain: 2 people, 18.18%
Non-Hodgkin's Lymphoma Recurrent (reoccurrence malignant (cancer) cells form in the lymph system): 2 people, 18.18%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 2 people, 18.18%
Hodgkin's Disease Recurrent (cancer originating from white blood cells -recurrent): 1 person, 9.09%
Hiv Test Positive: 1 person, 9.09%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Norvir and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously